http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012238222-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6035663b72f274c1815542eaa3571a54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J13-02
filingDate 2012-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95563a2f72a3208dfefede5d43ec0984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dd109c1dd73be10fb1633803a925fcc
publicationDate 2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2012238222-B2
titleOfInvention Dried formulations of nanoparticle-coated capsules
abstract A method of producing a dried formulation for an active substance such as a drug compound is described. The method involves dispersing a discontinuous phase (e.g. an oil-based or lipidic medium) comprising the active substance into a continuous phase (e.g. water) so as to 5 form a two-phase liquid system comprising droplets of said discontinuous phase, allowing nanoparticles to congregate at the phase interface at the surface of the droplets such that at least one layer of nanoparticles coat the droplets and thereby provide sufficient structural integrity to the droplets to enable the subsequent removal of the continuous phase, and thereafter removing the continuous phase from the nanoparticle-coated droplets to produce a 10 dried formulation.
priorityDate 2005-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6391321-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0247665-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004096515-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0478326-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004202682-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6585983-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414836370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5356789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408526047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409704282

Total number of triples: 37.